Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Mylan Inc    MYL   US6285301072

MYLAN INC (MYL)

48
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/16/2014 04/17/2014 04/21/2014 04/22/2014 04/23/2014 Date
47.21(c) 46.92(c) 48.32(c) 49.85(c) 50.28 Last
4 055 353 4 912 909 3 596 186 6 789 190 4 935 241 Volume
+2.12% -0.61% +2.98% +3.17% +0.86% Change
More quotes
Company
Mylan, Inc. is a generic and specialty pharmaceuticals company, through its subsidiaries, which develops, manufactures, markets and distributes pharmaceuticals. The company operates its business through two segments: Generics & Specialty. The Generics segment primarily develops, manufactures, sells... 
Surperformance© rating of Mylan Inc
Trading Rating : Investor Rating :
More about the company
Chart MYLAN INC
Duration : Period :
Mylan Inc Technical Analysis Chart | MYL | US6285301072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 7 926 M
EBIT 2014 2 085 M
Net income 2014 1 126 M
Debt 2014 5 948 M
Yield 2014 -
Sales 2015 8 498 M
EBIT 2015 2 284 M
Net income 2015 1 407 M
Debt 2015 4 962 M
Yield 2015 -
PER 2014 17,24
PER 2015 14,19
EV / Sales 2014 3,02x
EV / Sales 2015 2,70x
Capitalization 17 971 M
More Financials
Latest news on MYLAN INC
1h ago MYLAN : Launches First Generic ORTHO EVRA® Patch
5h ago MYLAN : Actavis Announces Agreement Related to Generess® FE Patent Challenge Lit..
10h ago MYLAN : Us court turns down teva's plea to block launch of natco's generic
1d ago Novartis, Valeant bids herald new deal-making era for pharma
5d ago MYLAN : Supreme Court Chief Justice Denies Teva's Request for an Injunction Rela..
04/16 MYLAN : Launches First Generic ORTHO EVRA® Patch
04/15 MYLAN : Announces Settlement Agreement for First-to-File Generess® Fe
04/15 MYLAN : Launches Generic Lunesta® Tablets
04/15 MYLAN : Prosonix and Mylan Enter Into Global Licensing Agreement for Generic Ver..
04/11 MYLAN : Submission of Matters to a Vote of Security Holders (form 8-K)
04/11 MYLAN : Federal Judge Enforces Settlement Agreement Between Mylan and Endo Regar..
04/11 MYLAN : Sets Date for 1st Quarter 2014 Financial Results Conference Call and Liv..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
Mylan Inc : Income Statement Evolution
More Financials
EPS Revisions
Mylan Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF